IL134996A0 - 6,11-bridged erythromycin derivatives - Google Patents

6,11-bridged erythromycin derivatives

Info

Publication number
IL134996A0
IL134996A0 IL13499698A IL13499698A IL134996A0 IL 134996 A0 IL134996 A0 IL 134996A0 IL 13499698 A IL13499698 A IL 13499698A IL 13499698 A IL13499698 A IL 13499698A IL 134996 A0 IL134996 A0 IL 134996A0
Authority
IL
Israel
Prior art keywords
erythromycin derivatives
bridged erythromycin
bridged
derivatives
erythromycin
Prior art date
Application number
IL13499698A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL134996A0 publication Critical patent/IL134996A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL13499698A 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives IL134996A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (fr) 1997-10-29 1998-10-29 Derives d'erythromycine a pont 6,11

Publications (1)

Publication Number Publication Date
IL134996A0 true IL134996A0 (en) 2001-05-20

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13499698A IL134996A0 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Country Status (23)

Country Link
EP (1) EP1027361B1 (fr)
JP (1) JP2001521038A (fr)
KR (1) KR20010031591A (fr)
CN (1) CN1278266A (fr)
AR (1) AR015986A1 (fr)
AT (1) ATE239750T1 (fr)
AU (1) AU1286799A (fr)
BG (1) BG104425A (fr)
BR (1) BR9813317A (fr)
CA (1) CA2307828A1 (fr)
CO (1) CO4990972A1 (fr)
DE (1) DE69814441T2 (fr)
DK (1) DK1027361T3 (fr)
ES (1) ES2198766T3 (fr)
HU (1) HUP0004323A2 (fr)
IL (1) IL134996A0 (fr)
NO (1) NO20002099L (fr)
PL (1) PL340253A1 (fr)
PT (1) PT1027361E (fr)
SK (1) SK6342000A3 (fr)
TR (1) TR200001140T2 (fr)
TW (1) TW486485B (fr)
WO (1) WO1999021864A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6-o-氨基甲酸酯-11,12-内酯-酮内酯抗菌剂
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
AU2003229037B8 (en) * 2002-05-13 2009-07-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
EP1509538A1 (fr) 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. Derives de l'erythromycine 6,11 bicyclique
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (fr) 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. Derives d'erythromycine 6-11 bicyclique
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (fr) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Composes macrocycliques pontes et procedes de preparation desdits composes
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
CN1278266A (zh) 2000-12-27
WO1999021864A1 (fr) 1999-05-06
NO20002099D0 (no) 2000-04-25
TR200001140T2 (tr) 2001-05-21
EP1027361A1 (fr) 2000-08-16
AU1286799A (en) 1999-05-17
TW486485B (en) 2002-05-11
ES2198766T3 (es) 2004-02-01
JP2001521038A (ja) 2001-11-06
DE69814441D1 (de) 2003-06-12
AR015986A1 (es) 2001-05-30
HUP0004323A2 (hu) 2001-02-28
NO20002099L (no) 2000-06-29
EP1027361B1 (fr) 2003-05-07
BG104425A (bg) 2001-01-31
PL340253A1 (en) 2001-01-29
PT1027361E (pt) 2003-09-30
SK6342000A3 (en) 2000-09-12
BR9813317A (pt) 2000-08-22
CA2307828A1 (fr) 1999-05-06
ATE239750T1 (de) 2003-05-15
CO4990972A1 (es) 2000-12-26
DE69814441T2 (de) 2004-04-08
DK1027361T3 (da) 2003-08-25
KR20010031591A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
ZA977687B (en) Substituted 6,5-hetero-bicyclic derivatives
IL128049A0 (en) Substituted 6,6-hetero-bicyclic derivatives
ZA985016B (en) C-4"-substituted macrolide derivatives.
ZA9811940B (en) Novel erythromycin derivatives.
ZA985018B (en) 9-oxime erythromycin derivatives.
HUP0001330A3 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
IL134220A0 (en) 6,9-bridged erythromycin derivatives
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
ZA9710648B (en) Erythromycin A derivatives.
PL340253A1 (en) 6,11-bridged derivatives of erythromycin
AU9649598A (en) Erythromycin a, 11,12-carbamate derivatives
AU9649698A (en) Erythromycin a 11, 12-carbamate derivatives
ZA982436B (en) Thiazolimine derivatives.
ZA983902B (en) Erythromycin derivatives.
ZA978546B (en) Erythromycin A derivatives.
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1027361T1 (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives
MXPA99011001A (es) Derivados de eritromicina multiciclicos.
ZA981307B (en) 4-aminoethoxyindazole derivatives.
HK1031385A (en) 6, 11-bridged erythromycin derivatives
HK1030782A (en) 6, 9-bridged erythromycin derivatives
GB9700702D0 (en) Erythromycin derivatives